Butobarbital
Barbiturate
- N05CA03 (WHO)
- AU: S8 (Controlled drug)
- CA: Schedule IV
- DE: Anlage II (Authorized trade only, not prescriptible)
- 5-Butyl-5-ethyl-1,3-diazinane-2,4,6-trione
- 77-28-1 Y
- 6473
- DB01353 Y
- 6229 Y
- OHZ8QAW6YC
- D02618 Y
- ChEMBL404422 Y
- DTXSID70227808
- Interactive image
- O=C1NC(=O)NC(=O)C1(CCCC)CC
- InChI=1S/C10H16N2O3/c1-3-5-6-10(4-2)7(13)11-9(15)12-8(10)14/h3-6H2,1-2H3,(H2,11,12,13,14,15) Y
- Key:STDBAQMTJLUMFW-UHFFFAOYSA-N Y
Butobarbital, also called butobarbitone or butethal, Soneryl, and Neonal,[1] is a hypnotic drug which is a barbiturate derivative.[2] It was developed by Poulenc Brothers (now part of Sanofi) in 1921.[3]
References
- ^ International Drug Names
- ^ Nordegren T (2002). "Butobarbital". The A-Z encyclopedia of alcohol and drug abuse. Parkland, Fla.: Brown Walker Press. p. 144. ISBN 978-1-58112-404-0.
- ^ DE 481129, "Verfahren zur Herstellung von n-Butylaethylbarbitursaeure", published 3 February 1922, issued 14 August 1929, assigned to ETS Poulenc Freres.
- v
- t
- e
Antihistamines | |
---|---|
Antidepressants | |
Antipsychotics |
Antidepressants | |
---|---|
Antipsychotics | |
Others |
- Agomelatine
- Melatonin
- Ramelteon
- Tasimelteon
- Cannabidiol
- Cannabis
- Chlorophenylalkyldiols
- Diethylpropanediol
- Evoxine
- Fenadiazole
- Guaifenesin-related muscle relaxants
- Midaflur
- Opioids (e.g., morphine)
- Passion flower
- Scopolamine
- Trazodone
- UMB68
- Valnoctamide
This sedative-related article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e